Mark Ungs

Mark Ungs General Information

Biography

Mr. Mark Ungs served as Chief Executive Officer, President & Board Member at InterValve. He recently served as the Vice President of New Business Development for Boston Scientific's multi-billion dollar Interventional Cardiology division where he was responsible for leading the division's growth outside its core businesses through internal development programs as well as external technology acquisitions into new therapies. He has played key roles in launching the two largest commercial successes in the history of the medical device industry, the drug coated stent and cardiac esynchronization therapy for CHF, representing billions in incremental revenue for his employers. In addition to InterValve, He is the co-founder of ACTx, a startup that is developing a therapy that has the promise of redefining the science of tissue function recovery and regeneration. He has over twenty years professional experience in the medical device industry. He has a degree in Chemical Engineering from Oregon State University and an MBA from the University of California, Berkeley.